Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate

Clinical trial NCT00262600 · COMPLETED

Trial details

NCT number: NCT00262600
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Atrial Fibrillation Stroke

Start date: 2005-12-01
Primary completion: 2009-04-01
Enrollment: 18113

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.